KTCN9

Keratoconus 9

Clinical Characteristics

Ocular Features:

Clinical information on one patient suggests that vision loss is first noted in the mid-teens and may be severe by age 23 years. Classical signs of keratoconus including corneal thinning, corneal ectasia, and a cone-shaped protrusion with Vogt's striae and a Fleischer's ring were present bilaterally.

Systemic Features:

No associated systemic abnormalities have been reported.

Genetics

Heterozygous mutations in the TUBA3D gene (2q21.1) have been found in 4 patients including monozygotic twin females. The mutation was not found in the parents of the twin sisters which suggests that the mutations arose de novo. Other mutations in the same gene have been found in two more unrelated individuals with keratoconus.

Other forms of hereditary keratoconus caused by different mutations are: KTCN1 (148300) mapped to a mutation in the VSX1 gene at 20p11, KTCN2 (608932) linked to a mutation on chromosome 16 (16q22.3-q23.1), KTCN3 (608586) by a mutation on chromosome 3 (3p14-q13), KTCN4 (609271) caused by a mutation on chromosome 2 (2p24), KTCN5 (614622) mapped to 5q14.1-q21.3, KTCN6 (614623) mapped to 9q34, KTCN7 (614629) mapped to 13q32, and KTCN8 (614628) mapped to 14q24.

Pedigree:

Autosomal dominant

Treatment

Treatment Options:

Treatment has not been reported but corneal transplantation can restore vision in many cases.

References

Article Title:

De novo mutations of TUBA3D are associated with keratoconus

Hao XD, Chen P, Zhang YY, Li SX, Shi WY, Gao H. De novo mutations of TUBA3D are associated with keratoconus. Sci Rep. 2017 Oct 19;7(1):13570.

PubMed ID:

29051577

You are here

Search For A Disorder